We detail below some organisations interested in adult immunisation. We also provide some links to information about vaccine preventable diseases impacting on older people. We will update this list every 3 months. [last updated January 2017]
Public Health England has reported that Pertussis vaccine coverage in pregnant women averaged 70% across May to September 2016, 14% higher than the same period in 2015.
Research published in 2015 in the Journal of Primary Prevention has estimated the cost of four of the most significant vaccine preventable diseases.
A systematic review of the relevant literature in English on the cost-effectiveness of immunisation for adults aged 50 years or over in all EU Member States was performed for the SAATI report (see below). Cost-effectiveness studies were found for 13 EU Member States (the UK, Germany, the Netherlands, Sweden, Belgium, France, Italy, Spain, Poland, Denmark, Finland, Slovakia and Czech Republic) and for 4 of the seven key vaccine preventable diseases examined in this report: herpes zoster, seasonal influenza, IPD and pneumococcal pneumonia.
The global incidence of pertussis is estimated at 48.5 million cases a year with 295,000 deaths [Mattoo 2005]. In the US, pertussis has the greatest incidence and mortality of all vaccine-preventable diseases [Roush 2007].
British GPs have driven up pertussis vaccine coverage in pregnant women from 55.1% to 57.7% in the six months from April to October 2015, higher than levels observed this time last year
View infographics presented by David Sinclair at the IFA’s Immunisation Champions Summit, Brussels 2015.
Research undertaken by Imperial College London has revealed that whilst awareness of the whooping cough vaccination (in a London sample) was at 63% among pregnant women, just 26% of this group had had actually been vaccinated.
New research on an ethnically diverse population of pregnant women in London reveals very low levels of uptake of the pertusis vaccination (26%) among the sample group.